Showing results (31-40 of 137) with videos related to
Sort By:
Pageof 14
International Journal of Molecular Sciences|December 11, 2025
Chronic Myeloid Leukemia and the T315I <i>BCR::ABL1</i> MutationFederico Pierro, Stefania Stella, Manlio Fazio, et al.International Journal of Molecular Sciences|March 27, 2025
Utilization of Machine Learning in the Prediction, Diagnosis, Prognosis, and Management of Chronic Myeloid LeukemiaFabio Stagno, Sabina Russo, Giuseppe Murdaca, et al.Anticancer Research|September 4, 2020
Second-line Dasatinib Therapy Improved Compliance and Deep Molecular Responses in Imatinib-intolerant Chronic Myeloid Leukemia PatientsUros Markovic, Anna Bulla, Salvatore Leotta, et al.Leukemia Research|April 8, 2004
Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patientsAnna Maria Santonocito, Ugo Consoli, Sabrina Bagnato, et al.Experimental Hematology|March 24, 2009
Effects of imatinib mesylate in osteoblastogenesisDaniele Tibullo, Cesarina Giallongo, Piera La Cava, et al.Journal of Clinical Medicine|April 27, 2024
Retinal Vessel Analysis and Microvascular Abnormalities in Patients with Philadelphia-Negative Chronic Myeloproliferative NeoplasmsAnna Maria Roszkowska, Rossana Leanza, Emanuela Aragona, et al.Frontiers in Pharmacology|April 8, 2026
Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIsMichele Massimino, Elena Tirrò, Chiara Romano, et al.Journal of Clinical Medicine|December 10, 2021
Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic CellsMichele Massimino, Paolo Vigneri, Stefania Stella, et al.Hematological Oncology|May 6, 2011
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donorsDaniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, et al.Current Pharmaceutical Design|October 25, 2012
Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cellsDaniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, et al.Pageof 14